✦ LIBER ✦

436 Enhancement of the tumour-specific T cell stimulation in renal cell carcinoma after expression of B7.1 and CD72

✍ Scribed by M. Siebels; K. Rohrmann; O. Reich; D. Zaak; A. Hofstetter

Book ID: 118645646
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 217 KB
Volume: 3
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(04)90433-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SIMULTANEOUS EXPRESSION OF T-CELL ACTIVA

SIMULTANEOUS EXPRESSION OF T-CELL ACTIVATING ANTIGENS IN RENAL CELL CARCINOMA: IMPLICATIONS FOR SPECIFIC IMMUNOTHERAPY

✍ RINGHOFFER, MARK; MÜLLER, CARLHEINZ R.; SCHENK, ARIANE; KIRSCHE, HANSPETER; SCHM 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 371 KB

Expression of B7.1 (CD80) in a renal cel

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

✍ Schendel, D J; Frankenberger, B; Jantzer, P; Cayeux, S; Nöβner, E; Willimsky, G; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 208 KB

Synergistic effects of IL-4 and TNFα on

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation

✍ Dagmar Quandt,Simon Jasinski-Bergner,Ulrike Müller… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 577 KB

Adjuvant autologous renal tumour cell va

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

✍ Dieter Jocham; Axel Richter; Lothar Hoffmann; Klaus Iwig; Dirk Fahlenkamp; Günth 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 103 KB

Expression of B7.1 in squamous cell carc

Expression of B7.1 in squamous cell carcinoma of the head and neck enhances proliferation and cytotoxicity of allogeneic and autologous lymphocytes

✍ S. Lang; R. Zeidler; B. Wollenberg; T. Whiteside 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Sorafenib reduces the percentage of tumo

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients

✍ Ingrid M.E. Desar; J. (Hans) F.M. Jacobs; Christina A. Hulsbergen-vandeKaa; Wim 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

## Abstract Tyrosine kinase inhibitors (TKIs) as sorafenib are known to reduce the number of immunosuppressive regulatory T cells (Tregs) in the peripheral blood and thereby shifting the immune balance to a more stimulating setting. The effect of sorafenib on intratumoural Tregs is unclear but impo